(Q45002399)

8 December 2017

Lipoprotein-associated phospholipase A2 level in patients with Behçet's disease (English)

1 reference

8 December 2017

0 references

1 reference

A Örem

1

1 reference

8 December 2017

S Yayli

2

1 reference

8 December 2017

D A Arıca

3

1 reference

8 December 2017

B Akcan

4

1 reference

8 December 2017

F B Yücesan

5

1 reference

8 December 2017

S Bahadir

6

1 reference

8 December 2017

3 July 2012

1 reference

Journal of the European Academy of Dermatology and Venereology

8 December 2017

1 reference

8 December 2017

27

1 reference

8 December 2017

3

1 reference

8 December 2017

e289-93

1 reference

The unique features of vasculitis in Behçet's syndrome

8 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

The expanding superfamily of phospholipase A(2) enzymes: classification and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

The role of lipoprotein-associated phospholipase A2 on cardiovascular disease risk assessment and plaque rupture: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behcet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infar

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

Lipoprotein-associated phospholipase A2: a risk marker or a risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

Patients with Behcet's disease carry a higher risk for microvascular involvement in active disease period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04631.X

10.1111/J.1468-3083.2012.04631.X

21 January 2018

Identifiers

DOI

1 reference

release_cgyfjpuowfalheb4vq4whhpz3y

8 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cgyfjpuowfalheb4vq4whhpz3y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference